CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
Reminder - The CTS Reentry form, CTS-00172, will be updated on Monday July 2, 2018. It's posted ...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...